Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED
Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
41 42 Next >
News headline image
Psychedelic Stock Gainers And Losers From September 22, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10 
Via Benzinga
News headline image
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... 
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... 
Via FinancialNewsMedia
Study Finds Using Social Media May Negatively Affect Youths’ Mental Health
Via Investor Brand Network
Study Finds That LSD Temporarily Reduces Binge Drinking in Rodents
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From September 21, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 
Via Benzinga
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences
Via Investor Brand Network
News headline image
Cybin to Participate in Upcoming Scientific and Investor Conferences
From Cybin Inc.
Via Business Wire
News headline image
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces R&B Milestones, Beats Anticipated Timeframe
Via Investor Brand Network
Hamilton Morris Confirmed as Keynote Speaker at Convergence Psychedelic Conference
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Clinical Trial Marks ‘Tremendous’ Milestone as First Participants Receive Initial CYB003 Dose
Via Investor Brand Network
News headline image
Cybin Achieves Research and Development Milestones Ahead of Projected Timelines
From Cybin Inc.
Via Business Wire
News headline image
Psychedelic Stock Gainers And Losers From September 19, 2022 ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65 
Via Benzinga
News headline image
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week ↗
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently. 
Via Talk Markets
News headline image
8 Largest Psychedelic Stocks Continued Their Decline Last Week ↗
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks. 
Via Talk Markets
News headline image
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64 
Via Benzinga
Study Suggests Reported Psychedelics Microdosing Effects Are Due to User Expectancy
Via Investor Brand Network
News headline image
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development
Via Investor Brand Network
Study Finds Hepatitis C Drugs May Help Alleviate Symptoms of PTSD
Via Investor Brand Network
News headline image
Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00 
Via Benzinga
How Psychedelic Legalization, Decriminalization and Medicalization Differ
Via Investor Brand Network
Topics Law Enforcement
News headline image
8 Largest Psychedelic Stocks Dropped Almost 12% This Week ↗
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From September 9, 2022 ↗
GAINERS: Allied (OTC:ALID) shares closed up 21.78% at $0.52 
Via Benzinga
News headline image
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) on Leading Edge of Psilocybin Research
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From September 7, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12 
Via Benzinga
Psychedelics May Make People Less Afraid of Death
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change... 
Via FinancialNewsMedia
Topics Supply Chain
News headline image
Psychedelic Stock Gainers And Losers From September 6, 2022 ↗
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS: 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.